GB0721094D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0721094D0 GB0721094D0 GBGB0721094.1A GB0721094A GB0721094D0 GB 0721094 D0 GB0721094 D0 GB 0721094D0 GB 0721094 A GB0721094 A GB 0721094A GB 0721094 D0 GB0721094 D0 GB 0721094D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0721094.1A GB0721094D0 (en) | 2007-10-26 | 2007-10-26 | Compounds |
| PCT/EP2008/064407 WO2009053448A1 (en) | 2007-10-26 | 2008-10-24 | Compounds which potentiate ampa receptor and uses thereof in medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0721094.1A GB0721094D0 (en) | 2007-10-26 | 2007-10-26 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0721094D0 true GB0721094D0 (en) | 2007-12-05 |
Family
ID=38830046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0721094.1A Ceased GB0721094D0 (en) | 2007-10-26 | 2007-10-26 | Compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0721094D0 (en) |
| WO (1) | WO2009053448A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015031249A2 (en) * | 2013-06-13 | 2017-07-25 | Veroscience Llc | treatment method, method for treating a metabolic disorder or a key element thereof, method for normalizing a daily dopamine release rate in the sumn, method for stimulating dopamine release from dopaminergic neurons in an individual's sumn and pharmaceutical composition |
| JP2019532106A (en) | 2016-10-14 | 2019-11-07 | ピーアイ インダストリーズ リミテッドＰｉ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ | 4-Substituted phenylamine derivatives and their use for protecting crops by combating undesired phytopathogenic microorganisms |
| GB201702221D0 (en) | 2017-02-10 | 2017-03-29 | Univ Of Sussex | Compounds |
| GB201803340D0 (en) | 2018-03-01 | 2018-04-18 | Univ Of Sussex | Compounds |
| WO2023154450A2 (en) * | 2022-02-11 | 2023-08-17 | Gilgamesh Pharmaceuticals, Inc. | (ampa-pam)-nmda receptor antagonist combination therapy for treatment of mental conditions and disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57197218A (en) * | 1981-05-29 | 1982-12-03 | Nippon Soda Co Ltd | Central nervous system depressant containing thiazoline- 5-carboxylic acid derivative |
| GB0608272D0 (en) * | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
-
2007
- 2007-10-26 GB GBGB0721094.1A patent/GB0721094D0/en not_active Ceased
-
2008
- 2008-10-24 WO PCT/EP2008/064407 patent/WO2009053448A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009053448A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0706793D0 (en) | Compounds | |
| GB0704394D0 (en) | Compounds | |
| GB0705672D0 (en) | Compounds | |
| GB0706173D0 (en) | Compounds | |
| GB0707092D0 (en) | Compounds | |
| GB0706165D0 (en) | Compounds | |
| GB0706168D0 (en) | Compounds | |
| GB0706188D0 (en) | Compounds | |
| GB0707034D0 (en) | Compounds | |
| GB0721094D0 (en) | Compounds | |
| GB0706174D0 (en) | Compounds | |
| GB0706189D0 (en) | Compounds | |
| GB0706167D0 (en) | Compounds | |
| GB0706187D0 (en) | Compounds | |
| GB0706164D0 (en) | Compounds | |
| GB0706170D0 (en) | Compounds | |
| GB0706190D0 (en) | Compounds | |
| GB0721092D0 (en) | Compounds | |
| GB0704939D0 (en) | Compounds | |
| GB0703756D0 (en) | Compounds | |
| GB0701955D0 (en) | Compounds | |
| GB0701985D0 (en) | Compounds | |
| GB0702973D0 (en) | Compounds | |
| GB0702863D0 (en) | Compounds | |
| GB0703067D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |